Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 226

1.

Impact of insulin-like growth factor 2, insulin-like growth factor receptor 2, insulin receptor substrate 2 genes polymorphisms on susceptibility and clinicopathological features of hepatocellular carcinoma.

Rashad NM, El-Shal AS, Abd Elbary EH, Abo Warda MH, Hegazy O.

Cytokine. 2014 Jul;68(1):50-8. doi: 10.1016/j.cyto.2014.02.006. Epub 2014 Mar 20.

PMID:
24656929
2.

Relationship of insulin-like growth factors system gene polymorphisms with the susceptibility and pathological development of hepatocellular carcinoma.

Weng CJ, Hsieh YH, Tsai CM, Chu YH, Ueng KC, Liu YF, Yeh YH, Su SC, Chen YC, Chen MK, Yang SF.

Ann Surg Oncol. 2010 Jul;17(7):1808-15. doi: 10.1245/s10434-009-0904-8. Epub 2010 Jan 30.

PMID:
20119675
3.

Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.

Motawi TK, Shaker OG, Ismail MF, Sayed NH.

Gene. 2013 Sep 25;527(2):516-20. doi: 10.1016/j.gene.2013.06.053. Epub 2013 Jul 9.

PMID:
23845776
4.

Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma.

Dong ZZ, Yao DF, Yao DB, Wu XH, Wu W, Qiu LW, Jiang DR, Zhu JH, Meng XY.

World J Gastroenterol. 2005 Aug 14;11(30):4655-60.

5.

[Association between polymorphisms of insulin-like growth factor receptor gene and susceptibility to non-small-cell lung cancer in Fujian Chinese].

Li HR, Chen YS, Shao H, Han LL, Zhang XE.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2012 Jun;29(3):300-5. doi: 10.3760/cma.j.issn.1003-9406.2012.03.012. Chinese.

PMID:
22678795
6.

Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients.

Li Y, Xie Q, Lu F, Zhao J, Mao P, Li Z, Liu S, Zhuang H.

Liver Int. 2010 Jan;30(1):112-8. doi: 10.1111/j.1478-3231.2009.02134.x. Epub 2009 Oct 15.

PMID:
19840254
7.

[Correlation between epigenetic alterations in the insulin growth factor-II gene and hepatocellular carcinoma].

Dong ZZ, Yao DF, Wu W, Qiu LW, Yao NH, Yan XD, Yu DD, Chen J.

Zhonghua Gan Zang Bing Za Zhi. 2012 Aug;20(8):593-7. doi: 10.3760/cma.j.issn.1007-3418.2012.08.011. Chinese.

PMID:
23207153
8.

Characteristics of hepatic igf-ii expression and monitored levels of circulating igf-ii mRNA in metastasis of hepatocellular carcinoma.

Qian J, Yao D, Dong Z, Wu W, Qiu L, Yao N, Li S, Bian Y, Wang Z, Shi G.

Am J Clin Pathol. 2010 Nov;134(5):799-806. doi: 10.1309/AJCPTFDSE2V3LCZP.

PMID:
20959664
10.

Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.

Li S, Deng Y, Chen ZP, Huang S, Liao XC, Lin LW, Li H, Peng T, Qin X, Zhao JM.

Infect Genet Evol. 2011 Dec;11(8):2083-8. doi: 10.1016/j.meegid.2011.09.025. Epub 2011 Oct 12.

PMID:
22019522
11.

Serum insulin-like growth factor-II as a serologic marker of small hepatocellular carcinoma.

Tsai JF, Jeng JE, Chuang LY, You HL, Wang LY, Hsieh MY, Chen SC, Chuang WL, Lin ZY, Yu ML, Dai CY.

Scand J Gastroenterol. 2005 Jan;40(1):68-75.

PMID:
15841717
12.

IL17A gene polymorphism, serum IL17 and total IgE in Egyptian population with chronic HCV and hepatocellular carcinoma.

ELBassuoni MA, Abd El Fatah G, Zaghla H.

Immunol Lett. 2015 Dec;168(2):240-5. doi: 10.1016/j.imlet.2015.09.004. Epub 2015 Sep 11.

PMID:
26367076
13.

Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.

Nardone G, Romano M, Calabrò A, Pedone PV, de Sio I, Persico M, Budillon G, Bruni CB, Riccio A, Zarrilli R.

Hepatology. 1996 Jun;23(6):1304-12.

PMID:
8675143
14.

Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.

Abbas E, Shaker O, Abd El Aziz G, Ramadan H, Esmat G.

Eur J Gastroenterol Hepatol. 2012 Apr;24(4):458-63. doi: 10.1097/MEG.0b013e3283508d45.

PMID:
22293333
15.

Single nucleotide polymorphisms associated with metastatic tumour antigen 1 overexpression in patients with hepatocellular carcinoma.

Lee SH, Chung YH, Kim JA, Lee D, Jin YJ, Shim JH, Jang MK, Cho EY, Shin ES, Lee JE, Park NH, Yu E, Lee YJ.

Liver Int. 2012 Mar;32(3):457-66. doi: 10.1111/j.1478-3231.2011.02648.x. Epub 2011 Sep 26.

PMID:
22098246
16.

[Relationship of insulin-like growth factor receptor single nucleotide polymorphism (SNP) with platinum-based chemotherapy outcomes in advanced non-small cell lung cancer].

Chen Y, Shao H, Li H, Han L, Zhang X.

Zhongguo Fei Ai Za Zhi. 2012 Feb;15(2):65-71. doi: 10.3779/j.issn.1009-3419.2012.02.01. Chinese.

17.

Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms.

Cantarini MC, de la Monte SM, Pang M, Tong M, D'Errico A, Trevisani F, Wands JR.

Hepatology. 2006 Aug;44(2):446-57.

PMID:
16871543
18.

Insulin-like growth factor-II is a useful marker to detect hepatocellular carcinoma?

Morace C, Cucunato M, Bellerone R, De Caro G, Crinò S, Fortiguerra A, Spadaro F, Zirilli A, Alibrandi A, Consolo P, Luigiano C, Resta ML, Ferraù O, Spadaro A.

Eur J Intern Med. 2012 Sep;23(6):e157-61. doi: 10.1016/j.ejim.2012.04.014. Epub 2012 May 24.

PMID:
22863442
19.
20.

Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma.

Sheu MJ, Hsieh MJ, Chiang WL, Yang SF, Lee HL, Lee LM, Yeh CB.

PLoS One. 2015 Apr 10;10(4):e0122961. doi: 10.1371/journal.pone.0122961. eCollection 2015.

Supplemental Content

Support Center